Neurology: Drugs
The question
To ask the Secretary of State for Health and Social Care, whether the Care Quality Commission's assessment framework requires providers to evidence medicines safety checks for psychiatric history, psychotropic medication use and previous psychiatric adverse drug reactions when prescribing neurological treatments with psychiatric warnings and contraindications.
Answered by Preet Kaur Gill
The Care Quality Commission’s (CQC) Single assessment framework includes a quality statement that requires service providers to ensure medicines and treatments are safe and meet people’s needs and preferences by enabling them to be involved in planning, including when changes to treatment and medication happen.
People’s medicines should be appropriately prescribed, supplied, and administered in line with relevant legislation or national guidance, and in line with the Mental Capacity Act 2005. Accurate and up-to-date information about people’s medicines should also be available and there should be appropriate arrangements for the safe management, use, and oversight of controlled drugs.
The CQC expects all medicines to be prescribed appropriately and that the prescriber has the necessary information about the patient to do so safely, which includes previous responses to medicines such as adverse drug reactions. Patients should be fully informed of the risks with any treatment, including any potential side effects.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →